| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 100 | 260 | 1,330 | $240 | $3.5M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 78 | 260 | 3,030 | $190 | $3.4M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 64 | 260 | 2,600 | $170 | $2.6M |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 117 | 180 | 1,490 | $320 | $2.2M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 52 | 110 | 960 | $70 | $1.7M |
| 74176 | The provider performs computed tomography of the abdomen and pelvis without contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 65 | 150 | 1,040 | $240 | $764.4K |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 75 | 160 | 1,640 | $110 | $710.7K |
| 70450 | The provider performed computed tomography, or CT scanning, of the head or brain, without contrast. He performs the procedure to diagnose any brain or intracranial abnormalities. | 94 | 180 | 1,770 | $80 | $635.2K |
| 72125 | In this diagnostic procedure, the provider performs a computed tomography, or CT, examination of the cervical spine without contrast material. | 92 | 110 | 1,070 | $170 | $482K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 102 | 170 | 3,560 | $30 | $397.9K |